Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09RHQ
|
||||
Former ID |
DAP001230
|
||||
Drug Name |
Ropivacaine
|
||||
Synonyms |
Naropin; ROPIVACAINE HCl; Ropivacaine hydrochloride; Ropivacaine monohydrochloride; Naropin (TN); Ropivacaine monohydrochloride, (S)-isomer; (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide; (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anesthetics
|
||||
Company |
AstraZeneca
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H26N2O
|
||||
InChI |
InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1
|
||||
InChIKey |
ZKMNUMMKYBVTFN-HNNXBMFYSA-N
|
||||
CAS Number |
CAS 84057-95-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9735, 7980538, 10258266, 14775095, 14799444, 26758019, 29203717, 33499545, 46504712, 57395234, 75873274, 91746030, 93166361, 96025176, 103743807, 104425084, 124403617, 129915887, 131327602, 137260968, 143315334, 160963644, 162179066, 172914458, 175266235, 179151279, 184545821, 184685755, 198991501, 212342552, 223365937, 223533434, 223904012, 226419989, 241147628, 251912273, 251916578, 252356499, 252390150, 252426878, 252453683
|
||||
SuperDrug ATC ID |
N01BB09
|
||||
SuperDrug CAS ID |
cas=038396393
|
||||
Target and Pathway | |||||
Target(s) | Voltage-gated sodium channel subunit alpha Nav1.8 | Target Info | Modulator | [556264] | |
Reactome | Interaction between L1 and Ankyrins | ||||
References | |||||
Ref 538331 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 078601. | ||||
Ref 542591 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7602). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.